SCHEMBL15309727

SCHEMBL15309727

CCOC(OCC)C(=O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.64
ALDH1A1 P00352 2/20 0.58
CES2 O00748 1/20 0.57
CES1 P23141 1/20 0.57
TP53 P04637 1/20 0.55
GAA P10253 1/20 0.54
TSHR P16473 2/20 0.54
SLC6A2 P23975 1/20 0.53
CHRNB4 P30926 1/20 0.53
CHRNA3 P32297 1/20 0.53
SLC6A3 Q01959 1/20 0.53
KMO O15229 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14571219 0.81 MAPK1 (0.53) ATMALDH1A1CES2CES1GAA
SCHEMBL11361315 0.81 ATM (0.53) ATMALDH1A1CES2CES1TP53
SCHEMBL5663759 0.80 ATM (0.65) ATMALDH1A1CES2CES1TP53
SCHEMBL3844160 0.80 ALDH1A1 (0.67) ALDH1A1CES2CES1TP53TSHR
SCHEMBL29408207 0.80 ALDH1A1 (0.67) ALDH1A1CES2CES1TP53TSHR
SCHEMBL3388760 0.79 NPC1 (0.62) ALDH1A1CES2CES1TP53GAA
SCHEMBL277073 0.79 GAA (0.57) ATMALDH1A1CES2CES1TP53
SCHEMBL2599194 0.78 ALDH1A1 (0.65) ALDH1A1CES2CES1TP53TSHR
SCHEMBL2599404 0.78 ALDH1A1 (0.65) ALDH1A1CES2CES1TP53TSHR
SCHEMBL27914715 0.78 CES2 (0.68) ALDH1A1CES2CES1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130324542-A1 [1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2013-12-05 US disclosed
EP-2650293-A1 [1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZINE COMPOUND, PREPARATION METHOD AND USE THEREOF Shanghai Institute Materia Medica, Chinese Academy Of Sciences (CN) 2013-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130324542-A1 [1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF MET, RET, ALK ATM 770/4885ALDH1A1 913/4885CES2 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.